ロード中...
Pharmacokinetic Interaction Between Fingolimod and Carbamazepine in Healthy Subjects
This open‐label, single‐sequence study in healthy subjects investigated the effects of steady‐state carbamazepine on the pharmacokinetic (PK) profile of a single 2‐mg dose of fingolimod. In period 1, a single oral dose of fingolimod 2 mg (day 1) was followed by PK and safety assessments up to 36 day...
保存先:
| 出版年: | Clin Pharmacol Drug Dev |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6099239/ https://ncbi.nlm.nih.gov/pubmed/29694732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.459 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|